• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

• Cytosurge Spins Off Its 3D Printing Business Unit (2019-08-21)
  The 3D Printing business unit of Cytosurge has been recognized as the technological global market leader for additive manufacturing of microscopically small metal components. We are pleased to announce as of today that all 3D Printing activities of Cytosurge will b...
• Rexgenero: Atelerix Consortium Gets £267k Innovate UK Grant (2019-08-21)
  Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI), welcomes the news announced today by Atelerix that it has been awarded a grant of £267,000 from Innovate UK. ...
• AZ: Phase 3 of Imfinzi/Tremelimumab in NSCLC Misses Endpoint (2019-08-21)
  AstraZeneca today announced final overall survival (OS) results from the Phase III NEPTUNE trial, a randomised, open-label, multi-centre, global trial of Imfinzi (durvalumab) in combination with tremelimumab, an anti-CTLA4 antibody, vs. standard-of-care (SoC) plati...
• Araris Biotech Raises CHF2.5m Seed Financing Round (2019-08-20)
  > Redalpine, Schroder Adveq and VI Partners participated in round > Proceeds to support development of own antibody-drug-conjugates (ADCs) Araris Biotech AG announced today the closing of an oversubscribed seed financing round of CHF 2.5 million with parti...
• Eppendorf AG Announces Results for First Half of 2019 (2019-08-20)
  > At €66.7 million, income from operations is at prior-year level > Strong growth in all sales regions and product groups > Targets for the entire year are confirmed The globally active Eppendorf Group charted a strong first half-year in 2019 with a si...
• Bayer to Sell Animal Health Business to Elanco for $7.6b (2019-08-20)
  Exit of Animal Health business completes the series of portfolio measures initiated by Bayer in November 2018 ahead of announced schedule / Enhances Bayer’s focus as a global leader in life sciences U.S.-based company Elanco Animal Health has entered into a de...
• Alligator Bioscience: China Antibody Agreement with Biotheus (2019-08-20)
  Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that a license agreement has been reached with Biotheus Inc. (“Biotheus”), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the license agreement, Alligator has granted Biotheu...
• Nabriva: FDA Approves Xenleta (lefamulin) for CABP (2019-08-19)
  > First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP > XENLETA Expected to be Available mid-September 2019 > Conference call and webcast t...
• Juvenescence Closes $100m Series B Round (2019-08-19)
  Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to increase human longevity, is pleased to announce the successful closure of its $100 ...
• Genentech and Roche Appoint Levi Garraway as CMO (2019-08-19)
  Dr. Sandra Horning, Chief Medical Officer and Head of Global Product Development will retire on December 31, 2019. During her decade-long tenure with Roche and Genentech, Dr. Horning brought 15 new medicines to patients and tackled some of the world’s toughest dise...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.